Solvay Will Supply Norway With Special Vaccines in Case of Influenza Pandemic

Solvay Pharmaceuticals has signed an agreement with the Norwegian authorities whereby Solvay Pharmaceuticals will supply influenza vaccines to Norway in the case of a pandemic. Thanks to the development of a new technology involving cell culture, Solvay Pharmaceuticals expects to have much greater flexibility for delivering special influenza vaccines in the event of a pandemic.

Big News Network (http://feeds.bignewsnetwork.com/redir.php?jid=e6c8fa77cd1dd938&cat=6dcd932030878143)